FDA Approves New Drug to Help Control Severe Asthma
Tezspire is unique in that it only targets thymic stromal lymphopoietin, the molecule involved in airway inflammation
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Emergency Medicine, Pediatrics, Pharmacy, Pulmonology, FDA Approvals, Source Type: news
More News: Allergy | Allergy & Immunology | Asthma | Emergency Medicine | Internal Medicine | Pediatrics | Respiratory Medicine